461 related articles for article (PubMed ID: 15329363)
21. Similar hematologic effects of long-term linezolid and vancomycin therapy in a prospective observational study of patients with orthopedic infections.
Rao N; Ziran BH; Wagener MM; Santa ER; Yu VL
Clin Infect Dis; 2004 Apr; 38(8):1058-64. PubMed ID: 15095207
[TBL] [Abstract][Full Text] [Related]
22. Linezolid compared with teicoplanin for the treatment of suspected or proven Gram-positive infections.
Wilcox M; Nathwani D; Dryden M
J Antimicrob Chemother; 2004 Feb; 53(2):335-44. PubMed ID: 14729745
[TBL] [Abstract][Full Text] [Related]
23. Linezolid in the treatment of implant-related chronic osteomyelitis.
Vercillo M; Patzakis MJ; Holtom P; Zalavras CG
Clin Orthop Relat Res; 2007 Aug; 461():40-3. PubMed ID: 17514011
[TBL] [Abstract][Full Text] [Related]
24. Efficacy and tolerability of daily-half dose linezolid in patients with intractable multidrug-resistant tuberculosis.
Park IN; Hong SB; Oh YM; Kim MN; Lim CM; Lee SD; Koh Y; Kim WS; Kim DS; Kim WD; Shim TS
J Antimicrob Chemother; 2006 Sep; 58(3):701-4. PubMed ID: 16857689
[TBL] [Abstract][Full Text] [Related]
25. Extended-interval aminoglycoside dosing for treatment of enterococcal and staphylococcal osteomyelitis.
Graham AC; Mercier RC; Achusim LE; Pai MP
Ann Pharmacother; 2004 Jun; 38(6):936-41. PubMed ID: 15084688
[TBL] [Abstract][Full Text] [Related]
26. Efficacy and safety of linezolid compared with vancomycin in a randomized, double-blind study of febrile neutropenic patients with cancer.
Jaksic B; Martinelli G; Perez-Oteyza J; Hartman CS; Leonard LB; Tack KJ
Clin Infect Dis; 2006 Mar; 42(5):597-607. PubMed ID: 16447103
[TBL] [Abstract][Full Text] [Related]
27. Complicated skin and skin-structure infections and catheter-related bloodstream infections: noninferiority of linezolid in a phase 3 study.
Wilcox MH; Tack KJ; Bouza E; Herr DL; Ruf BR; Ijzerman MM; Croos-Dabrera RV; Kunkel MJ; Knirsch C
Clin Infect Dis; 2009 Jan; 48(2):203-12. PubMed ID: 19072714
[TBL] [Abstract][Full Text] [Related]
28. Reversal of linezolid-associated cytopenias, but not peripheral neuropathy, by administration of vitamin B6.
Spellberg B; Yoo T; Bayer AS
J Antimicrob Chemother; 2004 Oct; 54(4):832-5. PubMed ID: 15317746
[TBL] [Abstract][Full Text] [Related]
29. Linezolid in the treatment of Gram-positive prosthetic joint infections.
Bassetti M; Vitale F; Melica G; Righi E; Di Biagio A; Molfetta L; Pipino F; Cruciani M; Bassetti D
J Antimicrob Chemother; 2005 Mar; 55(3):387-90. PubMed ID: 15705640
[TBL] [Abstract][Full Text] [Related]
30. Impact of linezolid on economic outcomes and determinants of cost in a clinical trial evaluating patients with MRSA complicated skin and soft-tissue infections.
McKinnon PS; Sorensen SV; Liu LZ; Itani KM
Ann Pharmacother; 2006 Jun; 40(6):1017-23. PubMed ID: 16720705
[TBL] [Abstract][Full Text] [Related]
31. Effectiveness and tolerability of prolonged linezolid treatment for chronic osteomyelitis: a retrospective study.
Senneville E; Legout L; Valette M; Yazdanpanah Y; Beltrand E; Caillaux M; Migaud H; Mouton Y
Clin Ther; 2006 Aug; 28(8):1155-1163. PubMed ID: 16982292
[TBL] [Abstract][Full Text] [Related]
32. The effectiveness and safety of oral linezolid for the primary and secondary treatment of osteomyelitis.
Aneziokoro CO; Cannon JP; Pachucki CT; Lentino JR
J Chemother; 2005 Dec; 17(6):643-50. PubMed ID: 16433195
[TBL] [Abstract][Full Text] [Related]
33. Use of linezolid in infants and children: a retrospective multicentre study of the Italian Society for Paediatric Infectious Diseases.
Garazzino S; Krzysztofiak A; Esposito S; Castagnola E; Plebani A; Galli L; Cellini M; Lipreri R; Scolfaro C; Bertaina C; Calitri C; Bozzola E; Lancella L; Quondamcarlo A; Bosis S; Pugni L; Losurdo G; Soresina A; De Gaudio M; Mariotti I; Mancini L; Gabiano C; Tovo PA
J Antimicrob Chemother; 2011 Oct; 66(10):2393-7. PubMed ID: 21764828
[TBL] [Abstract][Full Text] [Related]
34. Prospective, randomized study comparing quinupristin-dalfopristin with linezolid in the treatment of vancomycin-resistant Enterococcus faecium infections.
Raad I; Hachem R; Hanna H; Afif C; Escalante C; Kantarjian H; Rolston K
J Antimicrob Chemother; 2004 Apr; 53(4):646-9. PubMed ID: 14998986
[TBL] [Abstract][Full Text] [Related]
35. Preliminary experience with the use of oral linezolid in infants for the completion of antibiotic therapy in the outpatient setting after admission to the pediatric intensive care unit.
Sullivan J; Tobias JD
Am J Ther; 2006; 13(6):473-7. PubMed ID: 17122526
[TBL] [Abstract][Full Text] [Related]
36. Early switch from vancomycin to oral linezolid for treatment of gram-positive heart valve endocarditis.
Colli A; Campodonico R; Gherli T
Ann Thorac Surg; 2007 Jul; 84(1):87-91. PubMed ID: 17588391
[TBL] [Abstract][Full Text] [Related]
37. No effect of pyridoxine on the incidence of myelosuppression during prolonged linezolid treatment.
Plachouras D; Giannitsioti E; Athanassia S; Kontopidou F; Papadopoulos A; Kanellakopoulou K; Giamarellou H
Clin Infect Dis; 2006 Nov; 43(9):e89-91. PubMed ID: 17029128
[TBL] [Abstract][Full Text] [Related]
38. Safety and tolerability of linezolid.
French G
J Antimicrob Chemother; 2003 May; 51 Suppl 2():ii45-53. PubMed ID: 12730142
[TBL] [Abstract][Full Text] [Related]
39. Hematologic safety profile of linezolid in the early periengraftment period after allogeneic stem cell transplantation.
Cohen N; Mihu CN; Seo SK; Chung D; Chou J; Heller G; Papanicolaou GA
Biol Blood Marrow Transplant; 2009 Oct; 15(10):1337-41. PubMed ID: 19747643
[TBL] [Abstract][Full Text] [Related]
40. [Sideroblastic anemia after prolonged linezolid therapy].
Kakimoto T; Nakazato T; Miura R; Kurai H; Yamashita D; Sagara Y; Ishida A
Rinsho Ketsueki; 2008 Nov; 49(11):1566-8. PubMed ID: 19047790
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
